PCOS patients generally have insulin resistance, and IGF1 can enhance pancreatic β cell viability and inhibit apoptosis by activating the Sirt1/PI3K/Akt/FoxO1 pathway, inducing insulin secretion, and alleviating oxidative damage (Vinciguerra et al., 2009). Here, AKT1 is linked to polycystic ovary syndrome.